AU7815500A - A method for establishing connections between genes - Google Patents

A method for establishing connections between genes

Info

Publication number
AU7815500A
AU7815500A AU78155/00A AU7815500A AU7815500A AU 7815500 A AU7815500 A AU 7815500A AU 78155/00 A AU78155/00 A AU 78155/00A AU 7815500 A AU7815500 A AU 7815500A AU 7815500 A AU7815500 A AU 7815500A
Authority
AU
Australia
Prior art keywords
genes
establishing connections
establishing
connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78155/00A
Inventor
Ben-Zion Vider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GENENA Ltd
Original Assignee
BEN ZION VIDER
GENENA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEN ZION VIDER, GENENA Ltd filed Critical BEN ZION VIDER
Publication of AU7815500A publication Critical patent/AU7815500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
AU78155/00A 1999-10-18 2000-10-12 A method for establishing connections between genes Abandoned AU7815500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL132446 1999-10-18
IL13244699A IL132446A0 (en) 1999-10-18 1999-10-18 A method for establishing connections between genes
PCT/IL2000/000642 WO2001029210A1 (en) 1999-10-18 2000-10-12 A method for establishing connections between genes

Publications (1)

Publication Number Publication Date
AU7815500A true AU7815500A (en) 2001-04-30

Family

ID=11073346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78155/00A Abandoned AU7815500A (en) 1999-10-18 2000-10-12 A method for establishing connections between genes

Country Status (3)

Country Link
AU (1) AU7815500A (en)
IL (1) IL132446A0 (en)
WO (1) WO2001029210A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891718A (en) * 1996-03-27 1999-04-06 Vical Incorporated Tetracycline inducible/repressible systems
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
DE19639103A1 (en) * 1996-09-24 1998-03-26 Hoechst Ag DNA construct with inhibitory mutation and corrective mutation
DE19651443A1 (en) * 1996-12-11 1998-06-18 Hoechst Ag Self-reinforcing, pharmacologically controllable expression systems
DE19710643A1 (en) * 1997-03-14 1998-09-17 Hoechst Ag The promoter of the cdc25B gene and its use in gene therapy
GB9718952D0 (en) * 1997-09-05 1997-11-12 Medical Res Council Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods

Also Published As

Publication number Publication date
WO2001029210B1 (en) 2001-10-18
WO2001029210A1 (en) 2001-04-26
IL132446A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
WO2001007873A8 (en) A method for performing a transaction over a network
AU5304299A (en) Method for modifying chromosomes
AU1881201A (en) A descriptive-profile mercantile method
AU3315300A (en) Method for communicating information
AU2035201A (en) Method in a telecommunication system
AU6083200A (en) A communication system for general connection interface machines
AU2001249170A1 (en) Method for modifying a nucleic acid
AU2141400A (en) Method for a robot
AU5118000A (en) Method in a telecommunication system
AU1523501A (en) Communication method
AU6471600A (en) Wire sizing-rolling method
AU7815500A (en) A method for establishing connections between genes
AU2001236819A1 (en) Method for assembling a controlled impedance connector
AU3973800A (en) Method for preparing a sorting scheme
IL139524A0 (en) A method for establishing connections between genes
AU1283001A (en) Method for producing alkylhalogenosilanes
AU7010100A (en) Method for making a mini-smart card
AU5552200A (en) Method
AU1292301A (en) Method for genetic manipulation
AU7789000A (en) A method for the generation of repeat-depleted dna
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol
AU1141501A (en) Method for producing hydroxymethylpyridines
AU2151601A (en) A method for connecting structural elements
AU4484100A (en) Method for performing sizing-driven placement
AU2698700A (en) System for establishing a telephone connection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase